|
|
|
|
|
Richard L. Sherman Dick Sherman is a Venture Partner with SCP focusing on the life sciences area. Prior to joining SCP, he spent more than a decade (1976-1989) as Deputy General Counsel of SmithKline Beckman Corporation (now GlaxoSmithKline) and was founder and managing officer (1992-2001) of QED Technologies, Inc., a life science business consulting firm that is now a wholly-owned subsidiary of The Omnicom Group in New York. Dick has served on the Board of Directors of CytoMed, Inc., IBAH, Inc., Kenna Technologies, Inc., Mera Pharmaceuticals, Inc., and Sparta Pharmaceuticals. He also serves as Secretary and General Counsel of Hawaii Biotech, Inc., acts as a consultant to the law firm of Goodsill Anderson Quinn & Stifel, in Honolulu, and is a principal in CIP Capital, L.P. Dick is involved in a broad range of life sciences industry activities. He is a Venture Partner of Ventana Global, a venture fund located in Irvine, California, serves as Chairman of Directors at Biophage, Inc., and is a board member of the Sbarro Research Organization. He is also on the Technology Advisory Board for The Children's Hospital of Philadelphia and is a member of the Advisory Board of the University of Hawaii Medical School. Dick graduated magna cum laude from the University of Nebraska (1968), where he was elected to Phi Beta Kappa. He received his J.D. from New York University School of Law in 1971 as a Root-Tilden Scholar. Our Portfolio | SCP News | Contact Us |Submit a Business Plan © 2007 SCP Partners. All Rights Reserved. |
 Richard L. Sherman Winston J. Churchill Wayne B. Weisman Thomas G. Rebar Yaron Eitan Roger Carolin Robert G. Yablunsky John M. Keane Jim Evans Charles C. Freyer Dennis P. Ferry Danielle Kelly Revital Hirsch Ehud Barak |